Navigation Links
MedNet Solutions Proudly Welcomes Accelovance To The iMedNet Partner Program
Date:9/26/2013

MINNETONKA, Minn., Sept. 26, 2013 /PRNewswire/ -- MedNet Solutions, a global life sciences technology company specializing in clinical study management systems, is pleased to announce that Accelovance, an award-winning, full-service clinical research organization (CRO) focused in early phase Oncology, Vaccines and General Medicine development, has joined the iMedNet Partner Program.    Designation as an iMedNet Partner will facilitate Accelovance's ability to offer iMedNet EDC to clients as an advanced solution for the data management needs associated with clinical trial programs while providing significant cost savings compared with similar platforms. 

"MedNet is extremely pleased to partner with Accelovance, a recognized industry leader," remarked John M. (Rob) Robertson, President and CEO of MedNet Solutions. "Given their well-documented track record of continuously reducing study costs and timelines, their selection of iMedNet EDC to further improve study efficiency is a major testament to the tremendous benefits that iMedNet can deliver.  We look forward to working side-by-side with this growing organization and meeting their eClinical needs for many years to come."

"The adoption of the iMedNet technology further expands the breadth of available solutions within our data management offering.  We believe this is an attractive option for Sponsors having an early phase concentration and a desire to utilize a state of the art eClinical solution to enhance study efficiencies while maintaining budget discipline," noted Steve Trevisan, President and CEO of Accelovance.

Accelovance's focus on providing the best fit solutions and operational expertise has been a key driver in the growth trajectory of the company.  With their acquisition of Radiant Research to bolster their General Medicine experience, continued leadership position in the conduct of Vaccine trials, and key additions to their scientific and operational Oncology staff, they continue on a path of significant expansion.

Please contact MedNet Solutions for more information on iMedNet EDC or the iMedNet Partner Program, and Accelovance for additional details on their comprehensive lineup of clinical research services.

Stay in touch with MedNet:

About MedNet Solutions

MedNet Solutions is a leading healthcare technology company specializing in electronic data capture (EDC) and clinical trial management systems (CTMS) designed for the global life sciences market.  MedNet delivers proven, flexible and easy-to-use web-based eClinical solutions that effectively support clinical studies, registries and investigator initiated trials of all types and sizes.  Since 2001, MedNet has successfully supported pharmaceutical, medical device, biotechnology and contract research organizations (CROs) on clinical research conducted around the world.  These companies trust MedNet to consistently deliver the technology innovation, experience and reliability they need for success.  For more information, please visit www.mednetstudy.com.

About Accelovance

Headquartered in Rockville, Maryland, Accelovance is a privately held company that has developed a unique operational approach for delivering quality, on time, and cost effective clinical studies. The company was recognized as "Best CRO" with consecutive Industry Excellence awards in 2009, 2010 and 2011. Accelovance tailors its full offering of CRO services to present a clinical solution that meets a sponsor's needs. Accelovance has a 100% owned subsidiary providing CRO services in China. These capabilities can assist clients with global development programs or product registration in China, the fastest growing pharmaceutical market in the world.  For more information, visit the company's website at www.accelovance.com or follow them on Twitter at www.twitter.com/Accelovance.

Contact Information:
Dirk H. Nelson
Director of Marketing
MedNet Solutions
110 Cheshire Lane, Suite 300
Minnetonka, MN  55305
USA
(763) 258-2735

Michael Keens
Vice President, Sales & Marketing
Accelovance, Inc.
2275 Research Blvd, Suite 700
Rockville, MD  20850
USA
(240) 238-4941


'/>"/>
SOURCE MedNet Solutions
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. MedNet Solutions to Demonstrate Its Innovative Suite of eClinical Solutions at the 2012 Bio-IT World Conference & Expo
2. MedNet Solutions Announces Latest Enhancements To Its iMedNet EDC eClinical Solution
3. Statistics & Data Corporation Selects MedNet Solutions As Strategic Technology Partner
4. Advanced Clinical Joins MedNet Solutions iMedNet Partner Program
5. MedNet Solutions To Feature iMedNet EDC At The 2013 SCOPE Conference
6. MedNet Solutions To Spotlight iMedNet EDC At The 49th DIA Annual Meeting
7. Advance Research Associates Partners With MedNet Solutions
8. MedNet Solutions To Sponsor The SCDM Annual Conference For The Eighth Straight Year
9. Bowman provides strategies to engage public with climate change solutions
10. University of Minnesota startup offers game-changing energy solutions that reduce CO2 emissions
11. BioLife Solutions Announces 7th Consecutive Quarter of Record Revenue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2017)... March 2, 2017 Australian stem cell and ... CYP), has signed an agreement with the Monash Lung ... Biomedicine Discovery Institute and Department of Pharmacology at Monash ... further preclinical study to support the use of Cymerus™ ... Asthma is a chronic, long term ...
(Date:2/28/2017)... Feb. 28, 2017   Acuant , a leading ... announces significant enhancements to new and core technologies building ... products include mobile and desktop Acuant FRM TM ... - a real time manual review of identity documents ... provides the fastest and most accurate capture software to ...
(Date:2/28/2017)... Spanien, 27. Februar 2017  EyeLock LLC, ein marktführendes ... seine erstklassige biometrische Lösung zur Iris-Erkennung auf ... X16 LTE auf dem Mobile World Congress ... Qualcomm-Stand in Halle 3, Stand 3E10, vorstellen. ... Sicherheitsplattform Qualcomm Haven™ – eine Kombination aus ...
Breaking Biology News(10 mins):
(Date:3/28/2017)... -RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA:P6P2) ("RepliCel" ... clinical data from its phase 1/2 tendon repair study investigating ... (RCT-01) as a treatment for Achilles tendinosis. ... The clinical trial ... 6 months and showed no serious adverse events related to ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... fight against cancer, autoimmune disease and more through a single-cell precision engineering platform, ... proteomics analysis platform developed in the laboratory of Dr. James Heath at ...
(Date:3/27/2017)... , March 27, 2017  The global ... for 2016, according to a new report from ... lab testing is performed to evaluate disease progression, ... therapy, among other reasons.  The healthcare market research ... , provides an overview of the medical ...
(Date:3/27/2017)... ... March 27, 2017 , ... A research team ... vascular grafts in JoVE’s Video Journal, the world’s first peer-reviewed scientific video journal. ... of treating coronary artery disease (CAD). Lam is an assistant professor at the ...
Breaking Biology Technology: